The University of Angers is an institution of higher learning situated in the town of the same name, in western France. It was founded in 1356, closed down in 1793, and reestablished in 1971.The pre-revolutionary institution is sometimes looked upon as the precedent institution of the Catholic University of the West, though, as both popes and kings have granted charters to the old University of Angers, it is not a clear predecessor to either of the current Universities in Angers. Wikipedia.
French Institute of Health, Medical Research, Nantes University Hospital Center, University of Nantes, French National Center for Scientific Research and University of Angers | Date: 2013-05-14
The present invention concerns radioactive rhodium complexes, their preparation methods, and their use for the radiolabelling of biomolecules, especially monoclonal antibodies.
French Institute of Health, Medical Research, University of Nantes, Nantes University Hospital Center, French National Center for Scientific Research and University of Angers | Date: 2013-07-09
The present invention relates to a method for determining whether a cytomegalovirus infection in a transplanted patient is susceptible to induce allograft rejection comprising detecting the presence of at least one HLA-E-restricted CD8 T cell population displaying reactivity against peptides derived from the leader sequences of both HCMV-UL40 protein and allogeneic classical HLA-I molecules in a blood sample of the patient, wherein the presence of said populations indicated that the cytomegalovirus infection in the transplant patient is susceptible to induce allograft rejection.
Laboratoire Shigeta and University of Angers | Date: 2013-11-19
French Institute of Health, Medical Research, University of Nantes, Nantes University Hospital Center, French National Center for Scientific Research and University of Angers | Date: 2013-07-23
The present invention concerns materials and methods for characterizing monoclonal immunoglobulin specificity of a Monoclonal Gammopathy of Undetermined Significance (MGUS) or Myeloma patients using a protein microarray comprising (a) a substrate, (b) antigens immobilized on the substrate, said antigens being selected from a defined group consisting of infectious agent antigens and/or self-antigens. In particular said protein microarray may be used to improve diagnosis, for the prognosis of myeloma or MGUS, for preventing transformation of MGUS toward myeloma, for adapting treatment of MGUS and myeloma or for monitoring the response to therapy of MGUS and myeloma patients.
French National Center for Scientific Research, University of Angers and Wroclaw University of Technology | Date: 2013-10-23
A method for assessing turbulence parameters of a medium comprises the following steps: the illumination, by a laser beam being propagated in said medium, of a film of photochromic organic material that can comprise molecules of azobenzene, or of spyropyrane, or of stilbene, or of coumarin, or of fulgide, said illumination creating a surface grating in said film comprising scratches, the deformations of which are a function of the turbulence parameters; a step of acquisition of images comprising individual areas of structures linked to said scratches, more or less reduced and representative of the turbulence parameters of said medium; a step of processing of said images that makes it possible to assess the turbulence parameters of said medium. A device is also provided.